| Long name: |
Cy5 Conjugated, KLK9 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
5, Cy5 |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
KLK9 |
| Specificity: |
This is a highly specific antibody against KLK9 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic peptide derived from human KLK9 |
| Gene ID number: |
284366 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Rat, Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
Different splice variants of hK9 have been reported, Kallikrein 9 has been found in the ovary, Kallikrein 9 levels in breast cancer and uterine cancer patients have been reported to drop as the disease progresses, Kallikrein 9 was discovered as the locus for kallikreins on chromosome 19 was more fully mapped and found by similarity to the other tissue kallikreins, Pre-pro-kallikrein 9 has the 17 amino acid signal sequence is removed before secretion, The 234 amino acid form predicts a protein of 26 kDa with a pI of 9, The full length Kallikrein 9 encodes for a 250 amino acid protein, The shorter sequence also diverges before the catalytic serine residue, also known as Kallikrein-Like 3 (KLK-L3), although it is not yet known if they produce functional proteins, and the Pro-kallikrein 9 is activated to Kallikrein 9 by removal of the 5 amino acid propeptide domain, breast and neuronal tissues and is made by many cell lines in culture, is a chymotrypsin-like serine proteinase, making it unlikely to be proteolytically active, prostate, skin, testis, thus hK9 might be considered a favorable prognostic marker, thymus, with a predicted mass of 27, 5 kDa and a pI of 7, 53, 76 and this quite basic pI might give the shorter form a very different function or localization, Kallikrein 9 |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
625, 650nm/670nm |
| Synonyms: |
KLK-L3 |
| Properties: |
Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
KLK9 Conjugated |
| Short name: |
Conjugated, KLK9 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
Cy5 |
| Alternative name: |
cyanine 5 coupled, KLK9 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
6370 |
| Gene: |
KLK9 |
More about : KLK9 |
| Long gene name: |
kallikrein related peptidase 9 |
| Synonyms gene name: |
kallikrein 9 |
| Locus: |
19q13, 33 |
| Discovery year: |
2000-03-16 |
| GenBank acession: |
AF135026 |
| Entrez gene record: |
284366 |
| Pubmed identfication: |
16800724 16800723 |
| RefSeq identity: |
NM_012315 |
| Classification: |
Kallikreins |
| Havana BLAST/BLAT: |
OTTHUMG00000183087 |